Judge OKs 'False Marking' Claim Against Pharma Co.

Drug makers may be held liable for a "false marking" claim under a federal whistleblower law for printing expired patent numbers on product packages even when they have submitted accurate patent expiration dates for publication by the FDA, a federal judge has ruled.